Possible risk factors for the smear results at the end of intensive phase and anti- tuberculosis outcomes at the end of consolidation phase, respectively.

IQR, inter-quartile range.*For the data of 51 patients missed, 4253 patients’ data were analyzed.#For the data of 16 patients missed, 4288 patients’ data were analyzed. Successful outcomes defined as the completion of treatment and patients being cured. Unsuccessful outcomes defined as treatment failure, default and death because of ADRs due to DOTS therapy.